HODGKIN'S DISEASE MIXED CELLULARITY STAGE IV

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting HODGKIN'S DISEASE MIXED CELLULARITY STAGE IV:

# Drug Count
0 METHOTREXATE 3
1 METHOTREXATE SODIUM 3
2 INFLIXIMAB 2
3 BLEOMYCIN 1
4 BLEOMYCIN SULFATE 1
5 CISPLATIN 1
6 CYCLOPHOSPHAMIDE 1
7 CYCLOPHOSPHAMIDE FOR INJECTION 1
8 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 1
9 CYTARABINE 1
See all common drugs associated with HODGKIN'S DISEASE MIXED CELLULARITY STAGE IV

HODGKIN'S DISEASE MIXED CELLULARITY STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PROCARBAZINE HYDROCHLORIDE 1 0.0002
1 BLEOMYCIN SULFATE 1 0.0001
2 EZETIMIBE AND SIMVASTATIN 1 0.0001
3 CYTARABINE 1 0.0000
4 ETOPOSIDE 1 0.0000
5 CISPLATIN 1 0.0000
6 INFLIXIMAB 2 0.0000
7 METHOTREXATE SODIUM 3 0.0000
8 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
9 CYCLOPHOSPHAMIDE 1 0.0000
See all drugs enriched for association with HODGKIN'S DISEASE MIXED CELLULARITY STAGE IV